The crisis of homelessness is pushing American psychiatry to places it has not gone before — like sidewalk injections of ...

A new review has highlighted how skin tone can affect the safety and effectiveness of some medications and why the current ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review an ...

A systematic review and network meta-analysis of 68 studies has found no clear evidence that any specific antipsychotic ...

Clozapine is considered the drug of choice for treatment-resistant schizophrenia in guidelines globally, but it remains significantly underutilized. This is largely due to its range of side ...

Involuntary treatment saved me, and I never would have gotten my condition under control without medication. But the mental ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

The first schizophrenia medication in decades with a new mechanism of action won US regulatory approval today. The approval offers the hope of an antipsychotic that would be more effective and ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

The "Antipsychotic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global antipsychotic drugs market is ...